Merck announced it will pay $50 million for commercial rights to manufacture and develop the vaccine, invented at the Canadian federal government’s National Microbiological Laboratory in Winnipeg.
How is this a commercial success for Canadians? A US company that is essentially acting as a broker has scored a 244 times asset gain by flipping a Canadian invention to drug giant Merck for $ 50 million. Taxpayers got $205,000.
Surely, had the government lab that made the discovery been allowed to run and licence that patent, rather than PWGSC, I am sure they could have funded themselves for many years and still it would have been a bargain.
Why do we pay managers and executives to manage these things in the first place? That amount might not cover a single executive for a year. I hope they recoup some of it by divesting one executive.
No comments:
Post a Comment